Scientists from Tomsk Polytechnic University, in collaboration with an interdisciplinary research team, are currently ...
Revenio Group Corporation | Press Release | March 28, 2025 at 09:00:00 EET Icare, a subsidiary of Revenio Group, has today announced that the U.S. Food and Drug Administration (FDA) has cleared the ne ...
The development of ocular signs of neurofibromatosis type 1 (NF1) is only significant in patients 7 years of age and younger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback